Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
Researchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders to this treatment as well as for developing new treatments.
-
Researchers from the Massachusetts General Hospital Cancer Center in Boston have reported on a method for studying treatment resistance that may identify combinations of targeted therapies that can help to combat resistance in some patients.
-
Since they first began to be sold in North America in the mid-2000s, electronic cigarettes have been the subject of intense debate. NCI's Dr. Michele Bloch recently presented an update on some of the issues surrounding e-cigarettes.
-
NCI’s Director, Dr. Harold Varmus, introduces the NCI Annual Plan and Budget Proposal for Fiscal Year 2016.
-
NCI’s Dr. Doug Lowy discusses HPV vaccines, including their efficacy, safety, and the development of next-generation vaccines.